Mylan Pharmaceuticals

India’s mycobacterium tuberculosis tests market to grow at 4 per CAGR through 2033: GlobalData

Read more

NPPA fixes retail prices of 30 formulations, rejects four applications

Read more

Glenmark receives ANDA approval for Clobetasol Propionate Foam

Read more

Glenmark Pharma gets tentative nod from US FDA for acne treatment drug

Read more

Mylan launches MyHep All in India

Read more

Mylan launches Gilead Sciences’ Sovaldi tablets in India

Read more

Mylan launches generic Sofosbuvir tablets in India

Read more